TABLE 2.
No. | HLA subtypes | Position | Sequence | Molecular weight | References |
---|---|---|---|---|---|
n-Sp16 | HLA-A2 | 62-70 | VTWFHAIHV | 1109.3 | |
n-Sp17 | HLA-A2 | 424-432 | KLPDDFTGC | 995.12 | |
n-Sp18 | HLA-A2 | 515-524 | FELLHAPATV | 1097.28 | |
n-Sp19 | HLA-A2 | 721-729 | SVTTEILPV | 958.12 | |
n-Sp20 | HLA-A2 | 786-794 | KQIYKTPPI | 1087.33 | |
n-Sp21 | HLA-A2 | 817-826 | FIEDLLFNKV | 1237.46 | |
n-Sp22 | HLA-A2 | 821-829 | LLFNKVTLA | 1018.26 | |
n-Sp23 | HLA-A2 | 894-902 | LQIPFAMQM | 1078.35 | |
n-Sp24 | HLA-A2 | 964-972 | KQLSSNFGA | 951.05 | |
n-Sp25 | HLA-A2 | 976-984 | VLNDILSRL | 1042.24 | Sekine et al.18 |
n-Sp26 | HLA-A2 | 983-991 | RLDKVEAEV | 1058.2 | |
n-Sp27 | HLA-A2 | 1048-1056 | HLMSFPQSA | 1017.17 | |
n-Sp28 | HLA-A2 | 1062-1070 | FLHVTYVPA | 1046.23 | |
n-Sp29 | HLA-A2 | 1121-1129 | FVSGNCDVV | 939.05 | |
n-Ep1 | HLA-A2 | 16-24 | SVLLFLAFV | 1008.27 | |
n-Ep2 | HLA-A2 | 26-34 | FLLVTLAIL | 1002.31 | |
n-Ep3 | HLA-A2 | 50-58 | SLVKPSFYV | 1039.24 | Sekine et al.18 |
n-Mp1 | HLA-A2 | 15-23 | KLLEQWNLV | 1142.36 | Sekine et al.18 |
n-Mp2 | HLA-A2 | 26-35 | FLFLTWICLL | 1268.62 | |
n-Mp3 | HLA-A2 | 51-60 | LIFLWLLWPV | 1299.66 | |
n-Mp4 | HLA-A2 | 61-70 | TLACFVLAAV | 1007.26 | |
-Mp5 | HLA-A2 | 65-73 | FVLAAVYRI | 1051.3 | |
n-Mp6 | HLA-A2 | 89-97 | GLMWLSYFI | 1129.38 |
Synthetic purity of peptides was >95%.
Peptides were dissolved in DMSO.